Axsome Therapeutics, Inc. (AXSM)
253.63
+7.29
(+2.96%)
USD |
NASDAQ |
Jun 11, 16:00
257.57
+3.94
(+1.55%)
After-Hours: 17:56
Axsome Therapeutics Debt to Equity Ratio : 4.028 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 4.028 |
| December 31, 2025 | 2.470 |
| September 30, 2025 | 2.965 |
| June 30, 2025 | 3.057 |
| March 31, 2025 | 3.970 |
| December 31, 2024 | 3.559 |
| September 30, 2024 | 2.07 |
| June 30, 2024 | 1.865 |
| March 31, 2024 | 1.315 |
| December 31, 2023 | 0.9759 |
| September 30, 2023 | 0.6886 |
| June 30, 2023 | 0.6625 |
| March 31, 2023 | 1.321 |
| December 31, 2022 | 0.8642 |
| September 30, 2022 | 0.5994 |
| June 30, 2022 | 6.196 |
| March 31, 2022 | 3.421 |
| December 31, 2021 | 3.180 |
| September 30, 2021 | 1.172 |
| June 30, 2021 | 0.7007 |
| March 31, 2021 | 0.5205 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.4405 |
| September 30, 2020 | 0.3551 |
| June 30, 2020 | 0.1316 |
| March 31, 2020 | 0.1288 |
| December 31, 2019 | 0.1115 |
| September 30, 2019 | 2.896 |
| June 30, 2019 | 0.8063 |
| March 31, 2019 | 1.114 |
| December 31, 2018 | 7.368 |
| September 30, 2018 | 10.40 |
| June 30, 2018 | 1.209 |
| March 31, 2018 | 0.7316 |
| December 31, 2017 | 0.5941 |
| September 30, 2017 | 0.5993 |
| June 30, 2017 | 0.4383 |
| March 31, 2017 | 0.3366 |
| December 31, 2016 | 0.4515 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Indivior Pharmaceuticals, Inc. | -3.535 |
| Filana Therapeutics, Inc. | 0.00 |
| CorMedix, Inc. | 0.3315 |
| Eloxx Pharmaceuticals, Inc. | 0.00 |
| Cannabis Global, Inc. | -0.8033 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 713.61M |
| Total Liabilities (Quarterly) | 659.02M |
| Shareholders Equity (Quarterly) | 54.59M |
| Current Ratio | 1.392 |
| Net Debt Paydown Yield | -0.04% |